Skip to main navigation Skip to search Skip to main content

A Phase 3 Randomized Study Comparing Talquetamab in Combination with Pomalidomide (Tal-P), Teclistamab (Tal-Tec), and Inverstigator's Choice in Participants with Relapsed or Refractory Myeloma

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date08/5/24 → 08/4/26

Funding

  • Janssen Research and Development LLC: $149,420.00